← Eichor
Study identifier: NCT07120529 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Minimally Invasive Surgery Versus Open Radical Hysterectomy in Presumably Early Stage Cervical Cancer: a Retrospective Multicenter Non-inferiority Study Comparing Overall and Progression-free Survival.

Condition: Cervical Cancer · Hysterectomy  ·  Sponsor: Medical University of Silesia

PhaseN/A
Planned participants300
Who can joinFemale, 18 Years to 85 Years
Healthy volunteersNo

About this study

The goal of this retrospective observational study with prospective follow-up is to compare the safety and treatment outcomes of radical laparoscopic hysterectomy (removal of the uterus with cervix) versus abdominal (open) hysterectomy performed after the publication of the LACC trial in women with early-stage cervical cancer. Eligible participants will include adult, legally competent women diagnosed with early-stage cervical cancer (FIGO stages IB1-IIA1, excluding FIGO IB3) with negative sentinel lymph node biopsy (SNB) confirmed by ultrastaging. The main questions it aims to answer are: Is there a difference in overall survival (OS) and progression-free survival (PFS) between laparoscopic and abdominal radical hysterectomy? Are postoperative complication rates and recurrence patterns comparable between the two surgical approaches? Researchers will compare outcomes in patients undergoing radical laparoscopic hysterectomy versus abdominal hysterectomy to assess differences in survival, complications, and recurrence. Participants will: Have undergone radical hysterectomy (type B or C per Querleu-Morrow classification), preceded optionally by conization, with the use of uterine manipulators and absence of vaginal cuff protection explicitly excluded; Have had SNB as part of surgical staging; Be followed every 6 months for 5 years; Undergo clinical gynecologic examination and transvaginal and/or transabdominal ultrasound during follow-up; Undergo additional imaging (CT and…

This description comes directly from the study's public registry record.

Talk to the study team

Krzysztof Nowosielski, professor  ·  +48 502027943  ·  knowosielski@sum.edu.pl

Always discuss trial participation with your own doctor first.

Locations (5)

Uniwersyteckie Centrum Onkologii, Uniwersytecki Szpital Kliniczny w BiałymstokuBialystok, PolandNot Yet Recruiting
Department of Gynaecology, Obstetrics and Gynaecological Oncology, University Clinical Centre, Medical University of SilesiaKatowice, PolandRecruiting
Klinika Ginekologii, Świętokrzyskie Centrum Onkologii, Samodzielny Publiczny Zakład Opieki ZdrowotnejKielce, PolandNot Yet Recruiting
Oddział Ginekologii Onkologicznej z Pododdziałem Urologii, Opolskie Centrum OnkologiiOpole, PolandRecruiting
Department of Gynaecological Oncology,Wroclaw, PolandRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07120529